GB9320782D0 — Stabilising of proteins on solution
Assigned to University of Leeds Innovations Ltd · Expires 1993-12-01 · 32y expired
What this patent protects
PCT No. PCT/GB94/02180 Sec. 371 Date Jul. 1, 1996 Sec. 102(e) Date Jul. 1, 1996 PCT Filed Oct. 6, 1994 PCT Pub. No. WO95/10605 PCT Pub. Date Apr. 20, 1995A protein stabilizer additive comprises two or more of a tris compound of the formula (1): (HOCH2)3-C-R, wherein R is: C1-C4 a…
USPTO Abstract
PCT No. PCT/GB94/02180 Sec. 371 Date Jul. 1, 1996 Sec. 102(e) Date Jul. 1, 1996 PCT Filed Oct. 6, 1994 PCT Pub. No. WO95/10605 PCT Pub. Date Apr. 20, 1995A protein stabilizer additive comprises two or more of a tris compound of the formula (1): (HOCH2)3-C-R, wherein R is: C1-C4 alkyl, substituted C1-C4 alkyl, NH2; NR1R2 wherein R1 and R2 may be independently: H, C1-C4 alkyl sulphonate, C1-C4 hydroxyalkyl sulphonate; C1-C4 alkyl NHC(CH2OH)3, C1-C4 alkyl, C1-C4 hydroxyalkyl; C1-C4 alkyl carboxylate; a polyelectrolyte; a buffer; and one or more additional components for example divalent metal salts.
Drugs covered by this patent
- Ozempic (semaglutide) · Novo Nordisk
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.